Hot Flasher Weekly Recap — August 10 - August 14, 2026

Here’s everything we covered this week on Hot Flasher.

MONDAY — Your Brain, Your Gut, and the Doctor Who Wasn’t Taught Either

9:34 min

This episode covers three new papers from the NAMS journal: a SWAN ancillary study connecting midlife inflammatory biomarkers to future working memory, a randomized controlled trial on a probiotic formula for menopausal symptoms, and a narrative review exposing what medical schools are — and mostly aren’t — teaching about menopause. Research credibility and medical-system frustration lenses throughout.

Key Takeaways:

• Higher baseline GlycA (an inflammatory glycoprotein marker) was associated with lower future working memory in the SWAN HDL Ancillary Study — suggesting midlife inflammation may be a modifiable risk factor for cognitive decline.

• Complement proteins C3 and C4 showed a more complex picture: higher baseline complement factor 4 and increases in both C3 and C4 over time appeared cognitively protective, complicating a simple “less inflammation = better brain” narrative.

• A randomized controlled trial found a probiotic formula was associated with improvements in menopausal symptoms and quality of life — a real RCT result, not a supplement ad, though the researchers acknowledge more work is needed to confirm mechanism.

Sources:

• Inflammatory and immune biomarkers over midlife and future cognition in women: the SWAN HDL Ancillary Study

• Efficacy of a probiotic formula in the management of menopausal symptoms and quality of life: a randomized controlled trial

• Menopause education in undergraduate medical curricula: a narrative review of teaching models, content gaps, and learner preparedness

Listen to this episode →

TUESDAY — Your Lungs, Your Brain, and the Guidelines That Forgot You Exist

12:13 min

This episode looks at three new papers: one connecting diet, insulin resistance, and a specific kind of lung impairment in postmenopausal women; one calling out psychiatric treatment guidelines for failing midlife women during menopause; and one mouse study on a traditional Chinese herbal formula and its effects on brain inflammation. Nykki reads the methods, names what the evidence actually supports, and is direct about where each study falls short or raises something worth watching.

Key Takeaways:

• A 2026 cross-sectional study found that lower dietary quality in postmenopausal women was associated with a specific lung function pattern called PRISm — and insulin resistance appears to be part of the mechanism connecting diet to lung impairment.

• Cross-sectional studies cannot establish cause and effect — they show association, not direction — so this finding is hypothesis-generating, not actionable on its own.

• Australia and New Zealand’s psychiatric guidelines for schizophrenia largely ignore how menopause affects antipsychotic medication needs, leaving midlife women undertreated or incorrectly dosed at a critical biological transition.

Sources:

• Dietary quality, insulin resistance, and lung function in postmenopausal women

• RANZCP schizophrenia guidelines and the unmet needs of midlife women

• Chaihu Shugan San, microglial polarization, and hippocampal plasticity in menopausal mice

Listen to this episode →

WEDNESDAY — Flaxseed, Fake Diagnoses, and the Five-Minute Menopause Appointment

10:20 min

Today’s episode looks at a new flaxseed and Linusorb study claiming to ease menopausal symptoms through non-hormonal estrogen receptor activation, a rare breast cancer case report with a warning relevant to anyone in or around menopause, and new quality-improvement research on why menopause conversations in primary care are still falling short — and what’s actually being done about it.

Key Takeaways:

• A new study found flaxseed and Linusorb may reduce menopausal symptoms and bone loss by activating estrogen receptors non-hormonally, but the evidence base is early and the leap from mechanism to clinical recommendation is a long one.

• Metastatic breast cancer can spread to the cervix and endometrium and look exactly like a primary gynecologic cancer — a case report published today is a reminder that unusual gynecologic symptoms always warrant thorough workup, not assumptions.

• A 2026 quality improvement project found that structured tools and checklists in primary care significantly increased the rate of menopause conversations — but the fact that we need a QI project to get doctors talking about menopause tells its own story.

Sources:

• Flaxseed and Linusorb synergistically ameliorate menopausal symptoms through non-hormonal activation of estrogen receptors

• Metastatic breast cancer to the cervix and endometrium mimicking a primary gynecologic malignancy

• Facilitating menopause discussions in primary care: a quality improvement project

Listen to this episode →

THURSDAY — Fibroids, Fatty Liver, and Bones — Your Body Has Notes

9:37 min

This episode covers three studies published in August 2026 touching on fibroid care in the perimenopausal transition, fatty liver disease risk accumulation in postmenopausal women, and what standard DXA bone scans may not be capturing about bone metabolism. Nykki examines what the research actually says, where the gaps are, and why these conditions intersect with menopause more than most clinicians discuss.

Key Takeaways:

• Uterine fibroids (leiomyomas) affect up to 70-80% of women by age 50, but treatment decisions are still largely one-size-fits-all rather than tailored to symptom phenotype, reproductive stage, or long-term goals.

• A 2026 study found that in postmenopausal women, it’s not just body fat but the accumulation of multiple cardiometabolic risk factors together — insulin resistance, dyslipidemia, hypertension — that predicts more severe hepatic steatosis (fatty liver).

• Standard DXA scans measure bone density but don’t capture bone turnover rate — how fast bone is being broken down and rebuilt — which matters especially during and after menopause when that rate accelerates.

Sources:

• From prevalence to precision: Integrating phenotype, symptoms, reproductive goals, and treatment in leiomyoma care

• Adiposity and cumulative cardiometabolic risk factors as determinants of hepatic steatosis severity in postmenopausal women

• Bone turnover markers, DXA and mineral metabolism in long-term kidney transplant recipients: a cross-sectional comparative study

Listen to this episode →

FRIDAY — Your Chest X-Ray Might Know Your Bones Better Than You Do

9:17 min

This episode covers two new approaches to catching osteoporosis earlier in postmenopausal women — one using AI analysis of routine chest X-rays, one using a clinical prediction tool called a nomogram — plus a look at a newly defined syndrome called PMOS that links ovarian, metabolic, and cardiovascular risk in ways medicine is only beginning to map. All three studies published in August 2026.

Key Takeaways:

• A new AI tool can analyze routine chest X-rays to flag women who may need osteoporosis evaluation earlier — no additional scan required.

• A separately published nomogram offers a scoring model to help predict postmenopausal osteoporosis risk using clinical variables.

• Postmenopausal women with polycystic ovary syndrome (PCOS) history may carry elevated cardiometabolic risk under a newly proposed framework called PMOS.

Sources:

• Construction and validation of a nomogram for diagnosing postmenopausal osteoporosis

• AI-derived opportunistic screening using chest radiographs to identify bone mineral density patterns

• Cardiometabolic risk in postmenopausal women with polyendocrine metabolic ovarian syndrome (PMOS)

Listen to this episode →

Thanks for listening this week.

Got a menopause story to share? Tell us about it →

— Hot Flasher
hotflasher.com